Bionexus Gene Lab Stock Technical Analysis
| BGLC Stock | USD 0.59 0.01 2.59% |
As of the 25th of April, BioNexus Gene shows the Downside Deviation of 9.81, risk adjusted performance of 0.0618, and Mean Deviation of 12.48. BioNexus Gene Lab technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for BioNexus Gene Lab, which can be compared to its peers. Please confirm BioNexus Gene Lab information ratio and the relationship between the maximum drawdown and skewness to decide if BioNexus Gene Lab is priced correctly, providing market reflects its regular price of 0.595 per share. As BioNexus Gene Lab is a penny stock we also strongly suggest to validate its total risk alpha numbers.
BioNexus Gene Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioNexus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioNexusBioNexus |
BioNexus Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioNexus Gene Lab Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioNexus Gene Lab volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BioNexus Gene Lab Trend Analysis
Use this graph to draw trend lines for BioNexus Gene Lab. You can use it to identify possible trend reversals for BioNexus Gene as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioNexus Gene price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BioNexus Gene Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioNexus Gene Lab applied against its price change over selected period. The best fit line has a slop of 0.000036 , which means BioNexus Gene Lab will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted BioNexus Gene price change compared to its average price change.About BioNexus Gene Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioNexus Gene Lab on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioNexus Gene Lab based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioNexus Gene Lab price pattern first instead of the macroeconomic environment surrounding BioNexus Gene Lab. By analyzing BioNexus Gene's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioNexus Gene's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioNexus Gene specific price patterns or momentum indicators. Please read more on our technical analysis page.BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming. Bionexus Gene operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 27 people.
BioNexus Gene April 25, 2024 Technical Indicators
Most technical analysis of BioNexus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNexus from various momentum indicators to cycle indicators. When you analyze BioNexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0618 | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 12.48 | |||
| Semi Deviation | 8.31 | |||
| Downside Deviation | 9.81 | |||
| Coefficient Of Variation | 1200.81 | |||
| Standard Deviation | 36.76 | |||
| Variance | 1351.39 | |||
| Information Ratio | 0.0807 | |||
| Jensen Alpha | 4.63 | |||
| Total Risk Alpha | (1.98) | |||
| Sortino Ratio | 0.3024 | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 312.34 | |||
| Value At Risk | (19.42) | |||
| Potential Upside | 26.32 | |||
| Downside Variance | 96.18 | |||
| Semi Variance | 68.99 | |||
| Expected Short fall | (23.30) | |||
| Skewness | 7.01 | |||
| Kurtosis | 53.61 |
BioNexus Gene April 25, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioNexus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 4,343 | ||
| Daily Balance Of Power | 0.25 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 0.62 | ||
| Day Typical Price | 0.61 | ||
| Price Action Indicator | (0.02) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNexus Gene Lab. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for BioNexus Stock analysis
When running BioNexus Gene's price analysis, check to measure BioNexus Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNexus Gene is operating at the current time. Most of BioNexus Gene's value examination focuses on studying past and present price action to predict the probability of BioNexus Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNexus Gene's price. Additionally, you may evaluate how the addition of BioNexus Gene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is BioNexus Gene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNexus Gene. If investors know BioNexus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNexus Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (0.18) | Revenue Per Share 0.615 | Quarterly Revenue Growth (0.20) | Return On Assets (0.13) |
The market value of BioNexus Gene Lab is measured differently than its book value, which is the value of BioNexus that is recorded on the company's balance sheet. Investors also form their own opinion of BioNexus Gene's value that differs from its market value or its book value, called intrinsic value, which is BioNexus Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNexus Gene's market value can be influenced by many factors that don't directly affect BioNexus Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNexus Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNexus Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNexus Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.